Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.
about
Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomographyImaging the serotonin transporter during major depressive disorder and antidepressant treatmentQuantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imagingRisky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adultsSmall-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's diseaseA High-Resolution In Vivo Atlas of the Human Brain's Serotonin SystemDysregulation of D₂-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposureBDNF val66met association with serotonin transporter binding in healthy humansChanges in the α4β2* nicotinic acetylcholine system during chronic controlled alcohol exposure in nonhuman primates.Honesty mediates the relationship between serotonin and reaction to unfairness.A receptor-based model for dopamine-induced fMRI signal.Serotonin transporter binding and genotype in the nonhuman primate brain using [C-11]DASB PET.How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.Serotonin transporter availability in the amygdala and bed nucleus of the stria terminalis predicts anxious temperament and brain glucose metabolic activityHow the serotonin transporter 5-HTTLPR polymorphism influences amygdala function: the roles of in vivo serotonin transporter expression and amygdala structure.The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsyTest-retest measurements of dopamine D1-type receptors using simultaneous PET/MRI imaging.Modeling of PET data in CNS drug discovery and development.Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET dataAssociation of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleusImaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.A consistent and efficient graphical analysis method to improve the quantification of reversible tracer binding in radioligand receptor dynamic PET studies.D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model.Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.An optimization transfer algorithm for nonlinear parametric image reconstruction from dynamic PET dataPET imaging of neurokinin-1 receptors with [(18)F]SPA-RQ in human subjects: assessment of reference tissue models and their test-retest reproducibility.Dopamine beta-hydroxylase-deficient mice have normal densities of D(2) dopamine receptors in the high-affinity state based on in vivo PET imaging and in vitro radioligand binding.Empirical Bayesian estimation in graphical analysis: a voxel-based approach for the determination of the volume of distribution in PET studies.A linear model for estimation of neurotransmitter response profiles from dynamic PET data.Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.Translational possibility of [(18) F]Mefway to image serotonin 1A receptors in humans: Comparison with [(18) F]FCWAY in rodents.First-in-human evaluation of 18F-mefway, a PET radioligand specific to serotonin-1A receptors.Persistent dopamine functions of neurons derived from embryonic stem cells in a rodent model of Parkinson diseaseExploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor bindingMeasurement error analysis for the determination of dopamine D(2) receptor occupancy using the agonist radioligand [(11)C]MNPA.Dissociative changes in the Bmax and KD of dopamine D2/D3 receptors with aging observed in functional subdivisions of the striatum: a revisit with an improved data analysis methodFluoxetine administered to juvenile monkeys: effects on the serotonin transporter and behavior.PET imaging of acetylcholinesterase inhibitor-induced effects on α4β2 nicotinic acetylcholine receptor bindingIn-vivo human brain molecular imaging with a brain-dedicated PET/MRI system.Pixel-based absorption correction for dual-tracer fluorescence imaging of receptor binding potential.
P2860
Q24630426-F479DE64-E2FC-4883-8130-C90F1D1F83C1Q24683135-E2260096-2FA6-4012-9C0B-37F27F7CD502Q27023605-A9EA098C-8D2C-488D-8966-9D2338588EE9Q27306943-9D716B7B-0496-49ED-940F-3F4428C6ADFFQ27309046-11C8993F-B4AE-4248-9455-52F6D4239B78Q28125944-84779435-F096-4256-BD51-EC80BD6EE477Q28729938-F63ACBB9-8BE8-4E66-B54F-A56C89604479Q28806756-B1A4B421-C89C-4C19-A58C-8B2BEFA9B017Q30412977-3D456E99-FB4B-482A-B258-A9D48049FA65Q30413581-91D28053-68EF-4E38-A620-F6578B3A041BQ30434854-E356BEC0-B84E-4259-BE60-C7C6E75A2371Q30479400-AB297AD4-F316-4FE4-82FE-21CA468133A7Q30485725-53045E65-F58E-448B-AE9F-C4AFE46ADE5BQ30490740-17B6253E-74E0-49A4-B1FF-C4ED4C2A7E10Q30511878-82A9A367-0C73-4143-A671-AF37A4DCF283Q30540038-7FD1CC65-450F-4AD6-9CD2-8E6779D6764EQ30572286-BE7F1924-DA48-4C3E-ACAD-355348721938Q30623699-7D99D9DA-B8DB-4A67-BC19-771C4A129F37Q30722226-A92B791A-2B64-4B10-B494-15C811631826Q33634418-204A3180-024A-4D5B-AD41-64A6606C541EQ33637117-3D755F41-11C5-4EBC-A654-DAA404BCDE87Q33695259-92914E1C-144A-4ABD-9BA2-FC688D84C7F9Q33729233-77B81AC1-53F1-45F8-9E02-23E6954B6529Q33863502-854288F5-8856-4AC0-A715-292C545E6CE3Q33863682-5C294BF9-F210-44CE-9D27-59FE60DE0863Q33925457-C44A946F-8ED4-4382-9EBB-086992C682C9Q33949566-AE94BCDF-4B0A-45D6-8101-ABB86487AF72Q33958124-97D403A2-A972-43AF-B354-413D868B72C8Q33964638-55142C15-5DCE-451B-8A4F-BA4B4625ABF9Q34030711-26DC632F-BCE2-467D-9535-A6F95CF5ED70Q34041532-73EB26A7-A935-4740-8BFD-92A91A6F33C7Q34042581-B203DEFB-6CD8-4E9A-977C-ABFCD5FB802BQ34118080-94546E54-60B6-4D01-9F64-DB9B9E46E329Q34134231-41402B60-CA8E-44F4-A698-8D1955232BD7Q34170757-BAEB67CD-DF2A-430D-A587-0B0CE547AB5EQ34227983-EAFF6F40-280C-4B20-BB80-BC221674D23DQ34273623-18550D9C-9828-4939-BE75-7E492008BB57Q34361691-285C23D2-7D05-4B9A-B82D-8F20015B49E6Q34366557-F782A877-97EF-4835-8E4F-A3160F682B22Q34387497-251B6A8D-931C-4F43-82CC-47E1140EE03F
P2860
Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Linearized reference tissue pa ...... in transporter in human brain.
@ast
Linearized reference tissue pa ...... in transporter in human brain.
@en
Linearized reference tissue pa ...... in transporter in human brain.
@nl
type
label
Linearized reference tissue pa ...... in transporter in human brain.
@ast
Linearized reference tissue pa ...... in transporter in human brain.
@en
Linearized reference tissue pa ...... in transporter in human brain.
@nl
prefLabel
Linearized reference tissue pa ...... in transporter in human brain.
@ast
Linearized reference tissue pa ...... in transporter in human brain.
@en
Linearized reference tissue pa ...... in transporter in human brain.
@nl
P2093
P2860
P1476
Linearized reference tissue pa ...... in transporter in human brain.
@en
P2093
Akihiro Takano
Hiroshi Toyama
Jeih-San Liow
Kazutoshi Suzuki
Kendra Model
Masanori Ichise
Richard E Carson
Robert B Innis
Tetsuya Suhara
P2860
P304
P356
10.1097/01.WCB.0000085441.37552.CA
P577
2003-09-01T00:00:00Z
P6179
1002335609